HRP20040944B1 - Medicaments containing betamimetic drugs and a novel anticholinesterase drug - Google Patents

Medicaments containing betamimetic drugs and a novel anticholinesterase drug

Info

Publication number
HRP20040944B1
HRP20040944B1 HRP20040944A HRP20040944B1 HR P20040944 B1 HRP20040944 B1 HR P20040944B1 HR P20040944 A HRP20040944 A HR P20040944A HR P20040944 B1 HRP20040944 B1 HR P20040944B1
Authority
HR
Croatia
Prior art keywords
medicaments containing
novel
anticholinesterase drug
betamimetic
drugs
Prior art date
Application number
Inventor
Rolf Banholzer
Ingo Konetzki
Cristopher J Montague Meade
Helmut Meissner
Gerd Morschhaeuser
Michel Pairet
Michael A Pieper
Gerald Pohl
Richard Reichl
Georg Speck
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10256317A external-priority patent/DE10256317A1/en
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of HRP20040944A2 publication Critical patent/HRP20040944A2/en
Publication of HRP20040944B1 publication Critical patent/HRP20040944B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

The invention relates to novel medicament compositions based on long-acting beta2 agonists and salts of a novel anticholinesterase drug (I), to methods for the production of these compositions and their use in treating respiratory tract diseases.
HR20040944 2002-04-12 2004-10-11 Medicaments containing betamimetic drugs and a novel anticholinesterase drug HRP20040944B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10216428 2002-04-12
DE10256317A DE10256317A1 (en) 2002-04-12 2002-12-03 Synergistic medicaments used for treating inflammaSynergistic medicaments used for treating inflammatory or obstructive respiratory tract diseases, cotory or obstructive respiratory tract diseases, contain quaternized scopine ester anticholinergic agntain quaternized scopine ester anticholinergic agent and beta-mimetic agent e.g. salmeterol salt ent and beta-mimetic agent e.g. salmeterol salt
PCT/EP2003/003669 WO2003087097A1 (en) 2002-04-12 2003-04-09 Medicaments containing betamimetic drugs and a novel anticholinesterase drug

Publications (2)

Publication Number Publication Date
HRP20040944A2 HRP20040944A2 (en) 2005-04-30
HRP20040944B1 true HRP20040944B1 (en) 2012-12-31

Family

ID=29251756

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20040944 HRP20040944B1 (en) 2002-04-12 2004-10-11 Medicaments containing betamimetic drugs and a novel anticholinesterase drug

Country Status (19)

Country Link
EP (1) EP1497289B1 (en)
JP (1) JP2005529111A (en)
CN (1) CN1646527A (en)
AT (1) ATE302774T1 (en)
AU (1) AU2003232201B2 (en)
BR (1) BR0309185A (en)
CA (1) CA2481468C (en)
DK (1) DK1497289T3 (en)
ES (1) ES2248767T3 (en)
HR (1) HRP20040944B1 (en)
IL (1) IL164291A (en)
MX (1) MXPA04009916A (en)
NO (1) NO20044107L (en)
NZ (1) NZ536337A (en)
PL (1) PL213489B1 (en)
PT (1) PT1497289E (en)
RS (1) RS50735B (en)
UY (1) UY27757A1 (en)
WO (1) WO2003087097A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20040950A1 (en) 2003-02-14 2005-01-01 Theravance Inc BIPHENYL DERIVATIVES AS AGONISTS OF ß2-ADRENERGIC RECEPTORS AND AS ANTAGONISTS OF MUSCARINAL RECEPTORS
EP1577306A1 (en) * 2004-03-17 2005-09-21 Boehringer Ingelheim Pharma GmbH & Co.KG novel benzoxazinone derivatives as slow-acting betamimetics and use thereof in treatment of respiratory tract diseases
US7244728B2 (en) 2004-03-17 2007-07-17 Boehringer Ingelheim International Gmbh Long acting betamimetics for the treatment of respiratory diseases
US7745621B2 (en) 2004-05-14 2010-06-29 Boehringer Ingelheim International Gmbh Long acting bronchodilators for the treatment of respiratory diseases
WO2006089656A2 (en) 2005-02-25 2006-08-31 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
RU2442771C2 (en) 2005-08-08 2012-02-20 Арджента Дискавери Лтд Derivants of bicyclo[2, 2, 1] hept-7-ylamine and their applications
DE102005055957A1 (en) * 2005-11-24 2007-07-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation containing an anticholinergic
DE102005055963A1 (en) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation containing an anticholinergic
GB0602778D0 (en) 2006-02-10 2006-03-22 Glaxo Group Ltd Novel compound
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
JP5670421B2 (en) 2009-03-31 2015-02-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Component surface coating method
WO2010133294A2 (en) 2009-05-18 2010-11-25 Boehringer Ingelheim International Gmbh Adapter, inhalation device, and atomizer
SG181050A1 (en) 2009-11-25 2012-07-30 Boehringer Ingelheim Int Nebulizer
JP5658268B2 (en) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
EP2585151B1 (en) 2010-06-24 2018-04-04 Boehringer Ingelheim International GmbH Nebulizer
WO2012130757A1 (en) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medical device comprising a container
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (en) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Atomiser with coding means
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
WO2015018904A1 (en) 2013-08-09 2015-02-12 Boehringer Ingelheim International Gmbh Nebulizer
DK3139982T3 (en) 2014-05-07 2022-05-16 Boehringer Ingelheim Int Atomizer
PL3139984T3 (en) 2014-05-07 2021-11-08 Boehringer Ingelheim International Gmbh Nebulizer
AU2015257878B2 (en) 2014-05-07 2019-08-08 Boehringer Ingelheim International Gmbh Container, nebulizer and use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4108393A1 (en) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg NEW ESTERS BI-AND TRICYCLIC AMINO ALCOHOLS, THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS
DE10050994A1 (en) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma New diphenylalkanoic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease
DE10050995A1 (en) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma New benzylic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease

Also Published As

Publication number Publication date
IL164291A (en) 2012-04-30
IL164291A0 (en) 2005-12-18
PT1497289E (en) 2005-11-30
DK1497289T3 (en) 2005-10-24
JP2005529111A (en) 2005-09-29
UY27757A1 (en) 2003-11-28
CN1646527A (en) 2005-07-27
AU2003232201B2 (en) 2009-06-11
PL372450A1 (en) 2005-07-25
RS89804A (en) 2006-10-27
EP1497289A1 (en) 2005-01-19
PL213489B1 (en) 2013-03-29
EP1497289B1 (en) 2005-08-24
BR0309185A (en) 2005-02-15
NZ536337A (en) 2007-05-31
MXPA04009916A (en) 2005-05-03
WO2003087097A1 (en) 2003-10-23
CA2481468C (en) 2011-02-01
AU2003232201A1 (en) 2003-10-27
ATE302774T1 (en) 2005-09-15
CA2481468A1 (en) 2003-10-23
NO20044107L (en) 2004-11-04
ES2248767T3 (en) 2006-03-16
RS50735B (en) 2010-08-31
HRP20040944A2 (en) 2005-04-30

Similar Documents

Publication Publication Date Title
HRP20040944B1 (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
MXPA03005340A (en) Novel medicament compositions based on anticholinesterase drugs and on ciclesonides.
WO2004037807A3 (en) Medicinal arylethanolamine compounds
CY1106430T1 (en) MEDICATIONS FOR INHALATION CONTAINING VITAMINS AND AN ANTICHOLINEPG
UA86977C2 (en) Hydantoin derivatives for the treatment of obstructive airway diseases
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
WO2008022189A3 (en) Administration of high potency platinum compound formulations by inhalation
HUP0402217A2 (en) Platinum derivative pharmaceutical formulations
BR0009975B1 (en) powder inhaler for a combination medicine.
MXPA06013221A (en) Inhalation powder formulations containing enantiomerically pure beta-agonists.
MXPA03009849A (en) Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases.
SI1594885T1 (en) Medicament for inhibiting tumour growth
RS89904A (en) Medicaments containing steroids and a novel anticholinesterase drug
PL1643999T3 (en) Pyridoxamine for use in the treatment of diabetic neprhopathy in type ii diabetes
MXPA04002401A (en) Novel medicaments for inhalation.
MY141724A (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
BR0307703A (en) Drug compositions based on anticholinergic agents and egfr kinase inhibitors
MXPA02009603A (en) Divided dose therapies with vascular damaging activity.
DE50115277D1 (en) DRUG COMPOSITIONS FROM TIOTROPIUM SALTS AND
DK1581224T3 (en) Tiotropium-containing drug composition for inhalation
MY137679A (en) 2-ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders
UY27686A1 (en) NEW SALTS OF CINAMIC ACID, PROCEDURES FOR ITS PREPARATION AND ITS USE AS MEDICATIONS.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20120327

Year of fee payment: 10

B1PR Patent granted
PBON Lapse due to non-payment of renewal fee

Effective date: 20130410